Skip to content

Lifeline Endocardial Bipolar Lead 476-06

by Intermedics, Inc. 510(k)

Active United States

510(k) K853518

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK853518 Date5 Nov 1985ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
DTB
Device Class
Class III
Regulation
21 CFR Part 870.3680
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Lifeline Endocardial Bipolar Lead 476-06 is a Permanent Pacemaker Electrode, designed for endocardial placement within the heart. It delivers bipolar pacing and sensing capabilities to support cardiac rhythm management in patients requiring permanent pacemaker therapy.

This lead is intended for single-use implantation via venous access, typically positioned within the right atrium or ventricle. Supplied sterile and packaged for surgical use, it adheres to FDA 510(k) clearance under the Traditional pathway, classified as a Class III device under regulation 870.3680. Compatibility with MRI environments is not specified, and proper storage requires adherence to manufacturer guidelines to maintain sterility and functionality.

Other devices from Intermedics, Inc.

See all devices from Intermedics, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the Lifeline Endocardial Bipolar Lead 476-06, and where is it typically implanted in the body?

    The Lifeline Endocardial Bipolar Lead 476-06 is designed for permanent pacemaker therapy, providing bipolar pacing and sensing capabilities to manage cardiac rhythm disorders. It is intended for endocardial placement, meaning it is inserted through venous access and positioned within the right atrium or right ventricle of the heart during implantation.

  • Is this lead meant for single-use or can it be reused after implantation?

    This lead is explicitly intended for single-use implantation. It is supplied sterile and packaged for surgical use, so it should not be reused or reprocessed after implantation to ensure patient safety and device functionality.

  • How should the lead be stored to maintain its sterility and functionality before use?

    The manufacturer specifies that proper storage must follow their guidelines to preserve sterility and functionality. Since it is supplied sterile and packaged for surgical use, it should be stored in its original packaging, away from moisture, extreme temperatures, and contamination until ready for implantation.

  • What regulatory pathway was followed for FDA clearance of this device, and what class does it fall under?

    The Lifeline Endocardial Bipolar Lead 476-06 was cleared via the FDA 510(k) Traditional pathway and is classified as a Class III device under regulation 870.3680. This classification reflects its role in life-sustaining or supporting functions, requiring stringent regulatory oversight.